scholarly journals High-molecular-weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case-control study

2012 ◽  
Vol 10 (11) ◽  
pp. 2409-2412 ◽  
Author(s):  
B. SIEGERINK ◽  
F. R. ROSENDAAL ◽  
A. ALGRA
2009 ◽  
Vol 8 (11) ◽  
pp. 998-1005 ◽  
Author(s):  
Rolf T Urbanus ◽  
Bob Siegerink ◽  
Mark Roest ◽  
Frits R Rosendaal ◽  
Philip G de Groot ◽  
...  

Medicina ◽  
2019 ◽  
Vol 55 (2) ◽  
pp. 47
Author(s):  
Seyed Hashemi ◽  
Nourollah Ramroodi ◽  
Hamed Amiri Fard ◽  
Sahar Talebian ◽  
Maryam Haghighi Rohani ◽  
...  

Background and Objective: Evidence indicates that genetic factors may be involved in the risk of ischemic stroke (IS). The aim of this study was to assess the effect of genetic polymorphisms located in exons or untranslated regions of MTHFR as well as FV genes on ischemic stroke. Materials and Methods: In this case-control study, 106 patients with IS and 157 healthy volunteers (age <50 years) were genotyped for MTHFR C677T, A1298C, C2572A and C4869G, FVL, and prothrombin G20210A polymorphisms. Results: The MTHFR 677CT genotype was more frequent in patients and increased risk of IS with Odds Ratio = 1.9. The MTHFR A1298C and C2572A polymorphisms were not associated with IS in dominant and recessive models. Our findings showed a significant decrease in the MTHFR 4869CG genotype in IS patients, and this variant was associated with a decreased risk of IS in the dominant model. The CAAT haplotype was associated with increased risk, and the GAAC haplotype was associated with decreased risk of IS compared to other haplotypes. There was no relation between FVL G1691A polymorphism and IS risk. Conclusions: The present study showed that the MTHFR 677CT genotype was more frequent and the MTHFR 4869CG genotype was less frequent in young IS patients.


BMJ ◽  
1999 ◽  
Vol 318 (7175) ◽  
pp. 13-18 ◽  
Author(s):  
C L Chang ◽  
M. Donaghy ◽  
N. Poulter

BMJ ◽  
1995 ◽  
Vol 310 (6983) ◽  
pp. 830-833 ◽  
Author(s):  
C. Tzourio ◽  
A. Tehindrazanarivelo ◽  
S. Iglesias ◽  
A. Alperovitch ◽  
F. Chedru ◽  
...  

1997 ◽  
Vol 77 (06) ◽  
pp. 1179-1181 ◽  
Author(s):  
Stefan-Martin Herrmann ◽  
Odette Poirier ◽  
Pedro Marques-Vidal ◽  
Alun Evans ◽  
Dominique Arveiler ◽  
...  

SummaryThe GPIIb/IIIa receptor complex may contribute to acute coronary syndromes by mediating platelet aggregation. The Leu33/Pro polymorphism (PlAl/PlA2) of the GPIIIa has recently been shown to be associated with CHD in a small case-control study. We have investigated this polymorphism in a large multicenter study of patients with myocardial infarction and controls and found no difference in the distribution of allele and genotype frequencies between cases and controls.


Sign in / Sign up

Export Citation Format

Share Document